The cost and benefit of targeting amyloid plaques to treat alzheimer's disease
<p>Alzheimer's Ddisease (AD) is now the seventh leading cause of death in the United States. This incurable and fatal disease is becoming an increasingly concerning medical diagnosis. One feature of Alzheimer's disease is a build-up of the peptide amyloid-beta in the brain that progr...
Saved in:
Main Authors: | Marisa E Franklin (Author), Glen A Franklin (Author) |
---|---|
Format: | Book |
Published: |
Annals of Alzheimer's and Dementia Care - Peertechz Publications,
2023-12-30.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Amyloid-beta clearance in Alzheimer's disease
by: Robert Marr
Published: (2015) -
Amyloid-beta clearance in Alzheimer's disease: Does exercise play a role?
by: Reza Gharakhanlou, et al.
Published: (2020) -
Amyloid Diseases
Published: (2019) -
Identification of Multiple Targets in the Fight against Alzheimer's Disease
Published: (2020) -
Targeting Angiogenesis to Treat Autoimmune Diseases and Cancer
Published: (2020)